Abbott Must Give Docs To Alere Investors In Stock-Drop Suit

Abbott Laboratories must relay four months' worth of merger discussions to a proposed class of Alere Inc. investors suing Alere over a dip in its stock price while the companies were...

Already a subscriber? Click here to view full article